Second, the PORTAL trial, also from China (trial registry: NCT04400357), is a multicenter, phase III, patient-blinded, non-inferiority trial that aims to primarily assess and compare the time to functional recovery of patients who undergo robot-assisted versus open pancreatoduodenectomy for benign...